Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases Adela’s technology detects signals of early disease with high sensitivity through efficient mining of the entire methylome Initial applications of the genome-wide methylation enrichment technology to...